drugset / Trial / NCT02351700

Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors

NCT02351700 ↗

RandomizedParallel-groupDouble-blindSupportive care

Summary

A randomized, double-blind, placebo-controlled intervention trial involving 100 treated subjects undergoing endonasal trans-sphenoidal (ENTS) resection of pituitary lesion. Subjects will be randomized into two groups: 50 treated in the opioid-sparing arm and 50 treated in the standard post-operative medication arm.

Timeline

Start
2015-02-01
Primary completion
2016-03-01
Completion
2016-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator IV Caldolor Unknown 800 mg Intravenous

Indications